title: Analysing the structure of 23 clinical trials in multiple sclerosis.
abstract: At present many trials appear to be using subjective data, but using these data in an unsystematic and inappropriate way. In this context it is not surprising that subjective measures have a generally low status amongst investigators in clinical trials in MS. A more careful approach to such subjective measures would enable trials to take into account a significantly wider range of features. Controlled trials can then act as an important psychosocial as well as biomedical laboratory in the understanding of MS.
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D004311:Double-Blind Method; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D012008:Recurrence